14MUSD
Type
Common Stock
Exchange
PINK
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
-
CUSIP
-
Sector
Healthcare
Industry
Drug Manufacturers - General
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
0.32
PEG Ratio
-
Book Value
0.00
Dividend Share
-
Dividend Yield
-
Earnings Share
0.022
Wall Street Target Price
-
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
7,262,185
Gross Profit TTM
4,770,398
EBITDA
1,783,146
Profit Margin
10.47%
Return On Assets TTM
9.43%
Return On Equity TTM
38.21%
Revenue Per Share TTM
0.012
Qtly Revenue Growth YOY
-16.30%
Diluted Eps TTM
0.022
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.32
Forward PE
0
Price Sales TTM
1.9274
Price Book MRQ
0
Enterprise Value Revenue
0
Enterprise Value EBITDA
0
148.92
1.49%168.51
1.45%1164.50
1.07%141.42
0.72%264.24
0.01%133.70
-5.88%434.56
-1.62%54.04
-1.08%444.96
-0.68%270.66
-0.04%Profit.com is operated by Darqube Ltd, registered in England and Wales under company number 12197411.
Profit.com is an educational, subscription-based software platform providing financial market analytics and simulated trading using real-time market data and virtual funds. All trading activity on the platform is simulated. No real capital is used, no customer deposits are collected, and no real-money trades are executed or facilitated.
Profit.com is not a broker and does not provide brokerage, investment, or other financial services or investment advice. All content, tools and features are provided for educational and informational purposes only. Simulated trading results are hypothetical and are not indicative of actual or future results. The terms “trading” and “trader” refer exclusively to simulated activity on Profit.com and should not be interpreted as real-money trading or investing.